Companies: 10,795·Total market cap: $144.5T
Provention Bio, Inc.

Provention Bio, Inc.

PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio
52W High$25.0
52W Low$3.185
Overview

Provention Bio, Inc.(PRVB)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRVB · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2022-122021-122020-122019-122018-12
Assets
Cash & ST Investments$165.00M$127.13M$121.82M$85.37M$58.54M
Net Receivables$1.36M$0.00M$0.00M$0.00M$0.00M
Inventory$1.23M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$174.65M$101.10M$126.55M$86.00M$61.53M
PP&E Net$2.53M$2.38M$1.84M$0.00M$0.00M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$59.56M$0.00M$0.00M$0.00M$0.00M
Total Assets$236.86M$135.62M$128.52M($75.22M)$61.53M
Liabilities
Short-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Accounts Payable$6.76M$3.55M$7.57M$1.77M$0.57M
Total Current Liabilities$90.39M$22.79M$16.73M$3.84M$1.87M
Long-Term Debt$23.91M$0.59M$0.71M$0.00M$0.00M
Total Liabilities$115.01M$24.89M$306.16M$3.84M$1.87M
Stockholders Equity
Retained Earnings($405.64M)($292.07M)($177.64M)($79.06M)($35.78M)
Total Stockholders Equity$121.85M($292.07M)($177.64M)($79.06M)$59.66M
Total Liab & Equity(computed)$236.86M($267.19M)$128.52M($75.22M)$61.53M
Debt Summary
Total Debt$23.91M$0.59M$0.71M$0.00M$0.00M
Net Debt($20.13M)($77.60M)($101.58M)($39.16M)($58.54M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Provention Bio, Inc.

关于Provention Bio, Inc.(PRVB)资产负债表

Provention Bio, Inc.总资产$0.24B,现金及短期投资$0.17B,总负债$0.12B,总债务$0.02B,股东权益$0.12B。

常见问题

PRVB · 4 问

Provention Bio, Inc.总债务$0.02B,净债务($0.02B)。

PRVB total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10